Ava Schulz

Ava Schulz

Auto-generated profile, based on publicly available information

Ava Schulz

Department of Adult Psychiatry and Psychotherapy , Psychiatric University Clinic Zurich and University of Zurich , Zurich , Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MMMarta Anna Marciniak
Marta Anna Marciniak
LSLilly Shanahan
Lilly Shanahan
JRJudith Rohde
Judith Rohde
ASAva Schulz
Ava Schulz
CWCarolin Wackerhagen
Carolin Wackerhagen
BKBirgit Kleim
Birgit Kleim
Background: A growing number of psychological interventions are delivered via smartphones with the aim of increasing the efficacy and effectiveness of these treatments and providing scalable access to interventions for improving mental health. Most of the scientifically tested apps are based on cognitive behavioral therapy (CBT) principles, which are considered the gold standard for the treatment of most mental health problems. Objective: This review investigates standalone smartphone-based ecological momentary interventions (EMIs) built on principles derived from CBT that aim to improve mental health. Methods: We searched the MEDLINE, PsycINFO, EMBASE, and PubMed databases for peer-reviewed studies published between January 1, 2007, and January 15, 2020. We included studies focusing on standalone app-based approaches to improve mental health and their feasibility, efficacy, or effectiveness. Both within- and between-group designs and studies with both healthy and clinical samples were included. Blended interventions, for example, app-based treatments in combination with psychotherapy, were not included. Selected studies were evaluated in terms of their design, that is, choice of the control condition, sample characteristics, EMI content, EMI delivery characteristics, feasibility, efficacy, and effectiveness. The latter was defined in terms of improvement in the primary outcomes used in the studies. Results: A total of 26 studies were selected. The results show that EMIs based on CBT principles can be successfully delivered, significantly increase well-being among users, and reduce mental health symptoms. Standalone EMIs were rated as helpful (mean 70.8%, SD 15.3; n=4 studies) and satisfying for users (mean 72.6%, SD 17.2; n=7 studies). Conclusions: Study quality was heterogeneous, and feasibility was often not reported in the reviewed studies, thus limiting the conclusions that can be drawn from the existing data. Together, the studies show that EMIs may help increase mental health and thus support individuals in their daily lives. Such EMIs provide readily available, scalable, and evidence-based mental health support. These characteristics appear crucial in the context of a global crisis such as the COVID-19 pandemic but may also help reduce personal and economic costs of mental health impairment beyond this situation or in the context of potential future pandemics.

1 September 2022 in Emotion
Verified
Journal Article
Closed access
CPChristina Paersch
Christina Paersch
ASAva Schulz
Ava Schulz
FWFrank H. Wilhelm
Frank H. Wilhelm
ABAdam D. Brown
Adam D. Brown
BKBirgit Kleim
Birgit Kleim
Self-efficacy is a key construct in behavioral science with significant impact on mental health and wellbeing. A growing body of work has shown that perceptions of self-efficacy can be increased through recall of autobiographical episodes (AEs) of mastery ("self-efficacy memories") in experimental settings. Doing so contributes to improvements in clinically relevant processes, such as emotion regulation and problem solving. Here we examine whether the recall of self-efficacy AEs contributes to more adaptive appraisals for personally experienced negative memories. Seventy-five healthy individuals each identified an idiosyncratic personal negative memory that was screened for emotional attributes. Participants were then asked to either recall self-efficacy (SE, n = 25) or positive (POS, n = 25) autobiographical episodes. We investigated induction effects on subsequent reappraisals of the personal negative memories. The SE induction was associated with significant reductions in distress, and subjective physiological responses as compared to the POS induction. No significant induction effects emerged in autonomic regulation. These findings suggest that recalling self-efficacy episodes may promote adaptive self-appraisals for negative memories, which in turn may contribute to recovery from stressful events and, with further research, may prove to be a useful adjunctive strategy for treatments such as CBT. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

14 May 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
MMMiriam Müller-Bardorff
Miriam Müller-Bardorff
ASAva Schulz
Ava Schulz
CPChristina Paersch
Christina Paersch
DRDominique Recher
Dominique Recher
BSBarbara Schlup
Barbara Schlup
BKBirgit Kleim
Birgit Kleim
Background: Psychotherapies, such as cognitive behavioral therapy (CBT), currently have the strongest evidence of durable symptom changes for most psychological disorders, such as anxiety disorders. Nevertheless, only about half of individuals treated with CBT benefit from it. Predictive algorithms, including digital assessments and passive sensing features, could better identify patients who would benefit from CBT, and thus, improve treatment choices. Objective: This study aims to establish predictive features that forecast responses to transdiagnostic CBT in anxiety disorders and to investigate key mechanisms underlying treatment responses. Methods: This study is a 2-armed randomized controlled clinical trial. We include patients with anxiety disorders who are randomized to either a transdiagnostic CBT group or a waitlist (referred to as WAIT). We index key features to predict responses prior to starting treatment using subjective self-report questionnaires, experimental tasks, biological samples, ecological momentary assessments, activity tracking, and smartphone-based passive sensing to derive a multimodal feature set for predictive modeling. Additional assessments take place weekly at mid- and posttreatment and at 6- and 12-month follow-ups to index anxiety and depression symptom severity. We aim to include 150 patients, randomized to CBT versus WAIT at a 3:1 ratio. The data set will be subject to full feature and important features selected by minimal redundancy and maximal relevance feature selection and then fed into machine leaning models, including eXtreme gradient boosting, pattern recognition network, and k-nearest neighbors to forecast treatment response. The performance of the developed models will be evaluated. In addition to predictive modeling, we will test specific mechanistic hypotheses (eg, association between self-efficacy, daily symptoms obtained using ecological momentary assessments, and treatment response) to elucidate mechanisms underlying treatment response. Results: The trial is now completed. It was approved by the Cantonal Ethics Committee, Zurich. The results will be disseminated through publications in scientific peer-reviewed journals and conference presentations. Conclusions: The aim of this trial is to improve current CBT treatment by precise forecasting of treatment response and by understanding and potentially augmenting underpinning mechanisms and personalizing treatment. Trial Registration: ClinicalTrials.gov NCT03945617; https://clinicaltrials.gov/ct2/show/results/NCT03945617 International Registered Report Identifier (IRRID): DERR1-10.2196/42547

20 November 2024 in PsyArXiv
Verified
Preprint
Open access
LMLaura Elisabeth Meine
Laura Elisabeth Meine
CSCarmen Schaeuffele
Carmen Schaeuffele
DRDominique Recher
Dominique Recher
MMMiriam Müller-Bardorff
Miriam Müller-Bardorff
CPChristina Paersch
Christina Paersch
BKBirgit Kleim
Birgit Kleim
Background: While growing research confirms the efficacy of transdiagnostic cognitive behavioral psychotherapy (TD-CBT) by examining group-level changes from pre to post-treatment, less is known about inter-individual differences and dynamic changes during therapy. Understanding different symptom trajectories and their associations with treatment outcome would allow early detection of non-responders and treatment adjustments.Methods: Patients with anxiety disorders reported on demographics, clinical history, treatment motivation, and expectations before randomization to TD-CBT or wait-list. We analyzed data from the treatment group who provided symptom ratings every session and post-treatment follow-up (N = 64, 71.9% female, age: M = 32.67, SD = 11.91). Using latent class growth analysis (LCGA), we identified symptom trajectory classes and tested whether these could be predicted from baseline data. We also examined associations between classes and treatment outcome, using multilevel modeling and considering reliable change indices. Results: LCGA revealed four distinct trajectory classes: low severity - improved (32.81%), high severity - improved (29.69%), high severity-stagnant (18.75%), and low severity - worsened (18.75%). Only number of comorbidities emerged as a significant predictor of class, with patients in the high severity - stagnant group having more comorbidities. They also showed higher symptom severity at baseline and follow-ups compared to other classes, despite clear improvement.Conclusions: During TD-CBT, latent classes of symptom change can be distinguished and point to malleable factors already present at pre-treatment. Particularly patients with high initial burden and a higher number of comorbidities may require monitoring and adaptive treatment strategies, which should be explored in future studies.

8 September 2022 in JMIR Preprints
Verified
Preprint
Open access
MMMiriam Müller-Bardorff
Miriam Müller-Bardorff
ASAva Schulz
Ava Schulz
CPChristina Paersch
Christina Paersch
DRDominique Recher
Dominique Recher
BSBarbara Schlup
Barbara Schlup
BKBirgit Kleim
Birgit Kleim
BACKGROUND Psychotherapies, such as cognitive behavioral therapy (CBT), currently have the strongest evidence of durable symptom changes for most psychological disorders, such as anxiety disorders. Nevertheless, only about half of individuals treated with CBT benefit from it. Predictive algorithms, including digital assessments and passive sensing features, could better identify patients who would benefit from CBT, and thus, improve treatment choices. OBJECTIVE This study aims to establish predictive features that forecast responses to transdiagnostic CBT in anxiety disorders and to investigate key mechanisms underlying treatment responses. METHODS This study is a 2-armed randomized controlled clinical trial. We include patients with anxiety disorders who are randomized to either a transdiagnostic CBT group or a waitlist (referred to as WAIT). We index key features to predict responses prior to starting treatment using subjective self-report questionnaires, experimental tasks, biological samples, ecological momentary assessments, activity tracking, and smartphone-based passive sensing to derive a multimodal feature set for predictive modeling. Additional assessments take place weekly at mid- and posttreatment and at 6- and 12-month follow-ups to index anxiety and depression symptom severity. We aim to include 150 patients, randomized to CBT versus WAIT at a 3:1 ratio. The data set will be subject to full feature and important features selected by minimal redundancy and maximal relevance feature selection and then fed into machine leaning models, including eXtreme gradient boosting, pattern recognition network, and k-nearest neighbors to forecast treatment response. The performance of the developed models will be evaluated. In addition to predictive modeling, we will test specific mechanistic hypotheses (eg, association between self-efficacy, daily symptoms obtained using ecological momentary assessments, and treatment response) to elucidate mechanisms underlying treatment response. RESULTS The trial is now completed. It was approved by the Cantonal Ethics Committee, Zurich. The results will be disseminated through publications in scientific peer-reviewed journals and conference presentations. CONCLUSIONS The aim of this trial is to improve current CBT treatment by precise forecasting of treatment response and by understanding and potentially augmenting underpinning mechanisms and personalizing treatment. CLINICALTRIAL ClinicalTrials.gov NCT03945617; https://clinicaltrials.gov/ct2/show/results/NCT03945617 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/42547

1 January 2026 in Depression and Anxiety
Verified
Journal Article
Open access
PDF file
LMLaura E. Meine
Laura E. Meine
CSCarmen Schaeuffele
Carmen Schaeuffele
DRDominique Recher
Dominique Recher
MMMiriam Müller-Bardorff
Miriam Müller-Bardorff
CPChristina Paersch
Christina Paersch
BKBirgit Kleim
Birgit Kleim
Growing research confirms the efficacy of transdiagnostic cognitive behavioral psychotherapy, that is treatments applicable across multiple diagnoses within a disorder class or spectrum, by examining group‐level changes from pre‐ to posttreatment. However, less is known about interindividual differences and dynamic changes during therapy. Understanding different symptom trajectories and their associations with treatment outcome would allow early detection of nonresponders and treatment adjustments. Using data from the treatment group of a randomized controlled trial, we aimed to investigate trajectories in transdiagnostic cognitive behavioral therapy (CBT) with the Unified Protocol (UP) in patients with anxiety disorders. Patients reported on demographics, clinical history, coping strategies, treatment motivation, and expectations before starting transdiagnostic CBT. Participants provided symptom ratings across 16 sessions of the UP as well as at posttreatment, 6‐, and 12‐month follow‐up ( N = 64, 71.9% female, age: M = 32.67, SD = 11.91). Using latent class growth analysis (LCGA), we identified symptom trajectory classes and tested whether these could be predicted from baseline data. We also examined associations between classes and treatment outcome, using multilevel modeling and reliable change indices (RCIs). LCGA revealed four distinct trajectory classes: low severity—improved ( n = 21, 32.81%), high severity—improved ( n = 19, 29.69%), high severity—stagnant ( n = 12, 18.75%), and low severity—worsened ( n = 12, 18.75%). Only the number of comorbidities emerged as a significant predictor of class, with patients in the high severity—stagnant group having more comorbidities. They also showed higher symptom severity at baseline, posttreatment, and follow‐ups compared to other classes, despite clear improvement. Latent classes of symptom changes during transdiagnostic CBT can be distinguished and important pretreatment factors identified, informing treatment selection and personalization. Particularly patients with high initial burden and a higher number of comorbidities may require monitoring and adaptive treatment strategies, which should be explored in future studies. Trial Registration: ClinicalTrials.gov identifier: NCT03945617